Filter
Exclude
Time range
-
Near
Congrats, Erik McInnes MSc'27 Candidate for winning the BD Biosciences Discover Day Advanced Cytometry Research Innovation Award! Erik is first in Canada to use new BD FACSDiscover A8 Cell Analyzer with CellView. Continuing to unlock its potential for immunology research. 👏👏👏
1
2
145
🌟Major Milestone🌟 We are excited to announce the installation of FACSDiscover™️ S8 imaging spectral flow cytometer and cell sorter in the BRIC-NIBMG Core Facility. This advanced platform will enable simultaneous imaging and spectral detection of 44 different parameters from individual cells. Researchers can now: ✅ Capture Morphological Insights – Visualise cells as acquired and sorted, enabling deeper phenotyping ✅ Spectral Precision – Resolve complex fluorophore panels ✅ AI-Driven Analysis – Leverage advanced algorithms for smarter gating and decision-making This technology will empower ongoing cutting-edge projects on multi-omic integration, single-cell studies, immune profiling, tumour heterogeneity, rare cell isolation, and next-level functional insights, setting a new standard of Biomedical Research at NIBMG. We look forward to collaborating on groundbreaking discoveries @BricDbt @DBTIndia @DrJitendraSingh @rajesh_gokhale @DrSagarSengupta #FACSDiscoverS8 #CellView #SpectralFlow #FlowCytometry #BDBiosciences #Sahaj
4
10
435
24 Oct 2025
#GWSMHS & the GW Cancer Center recently received a grant from @NIH to purchase a state-of-the-art BD FACSDiscover™ S8 CellView spectral flow cytometer & live cell sorter, which will enhance research in cancer, immunology, & cellular therapeutics: bit.ly/4o66WdI
2
128
👓 $EL EssilorLuxottica – Résultats S1 2025 🇫🇷 Un semestre très solide dans un environnement complexe, avec une forte montée en puissance des lunettes intelligentes. 🔹 Chiffre d'affaires : 14,0 Mds € 5.5% en publié | 7.3% à taux constants → Toutes les zones géo en croissance, avec une mention spéciale pour l’EMEA ( 9.5%) 🔹 Résultat opérationnel ajusté : 2,53 Mds € → Marge stable à 18.3%, malgré les droits de douane US 🔹 Résultat net : 1,39 Md € ( 1.6%) 🔹 Free Cash Flow : 951 M€ → Solide, mais en recul YoY 🔹 DTC (vente directe) : 10.2% → Continue de surperformer la vente en gros ( 4.2%) → Forte croissance en e-commerce & retail, notamment via Ray-Ban.com & SunglassHut 🔍 Lunettes IA : la révolution continue Ray-Ban Meta triple son chiffre d’affaires en un an ⁉️ → Essor en Europe, Inde, Mexique, EAU → Nouvelles fonctions : traduction IA, vidéo live, commandes vocales Instagram Lancement d’Oakley Meta avec IA embarquée : • Verres PRIZM IA • Enregistrement 3K • Autonomie 8h étui 48h • Haut-parleurs invisibles → Ciblage sport et outdoor 👂 Nuance Audio (lunettes auditives connectées) déjà dispo dans 10 000 points de vente → Solution certifiée FDA et CE pour déficience auditive légère à modérée → Déploiement rapide en Europe 🏥 En parallèle, EssilorLuxottica trace sa route med-tech : → Acquisition des cliniques Optegra (ophtalmologie - UK, NL, CZ, Pologne) → Intégration de Cellview (diagnostic rétinien) → Achat de Pulse Audition (IA audio) 🎯 Objectif 2026 maintenu : • CA : 27-28 Mds € • Marge opérationnelle ajustée : 19-20 % 💬 EssilorLuxottica n’est plus seulement un fabricant de lunettes. C’est un acteur healthtech & IA qui transforme vos lunettes en plateforme d’assistance visuelle, cognitive et auditive. Une thèse long terme de plus en plus crédible. $EL 👁️‍🗨️
👁️ Un Géant Français de la Vision – EssilorLuxottica $EL 🇫🇷 Essilor est un acteur mondial de la santé visuelle et du lifestyle, né de la fusion en 2018 entre Essilor (leader des verres correcteurs) et Luxottica (leader des montures et marques comme Ray-Ban, Oakley ou Persol). Sa particularité ? ➡️ Une intégration verticale unique au monde : EssilorLuxottica conçoit, fabrique et vend ses produits, en maîtrisant toute la chaîne en passant par les verres jusqu’à la distribution au client final, via un réseau de plus de 17000 magasins. Ce modèle lui permet de : 🔸Capturer une large part de la valeur, 🔸Optimiser ses marges, 🔸Imposer ses standards technologiques (Transitions, Stellest, Ray-Ban Meta). Le groupe est actif dans plus de 150 pays, avec des positions dominantes en Europe, Amérique du Nord et Asie. Il adresse tous les segments : verres, lunettes de soleil, lunettes connectées, optique de prescription, et investit dans les medtechs. Discret mais massif, EssilorLuxottica combine : 🔸Des marques iconiques, 🔸Une mission de santé publique (corriger la vue), 🔸Une stratégie d’innovation ambitieuse pour rester au cœur de notre vision One Pager 👇
3
5
27
6,959
EssilorLuxottica $EL, fabricante de Ray-Ban, compra Optegra, que gestiona más de 70 hospitales oftalmológicos en toda Europa, para impulsar la atención oftalmológica basada en IA. La operación se basa en adquisiciones recientes en tecnología médica como Heidelberg Engineering y Cellview Imaging.
1
6
733
Ray-Ban maker EssilorLuxottica is buying Optegra, which runs 70 eye hospitals across Europe, in a push into AI-driven eyecare. Deal builds on recent med-tech buys like Heidelberg Engineering and Cellview Imaging.
22
9
56
11,112
“We are happy to welcome Cellview’s team to EssilorLuxottica and to work together to accelerate our strategy in vision health" @EssiLux buys Canadian med-tech start-up Cellview, which specialises in diagnostics through the use of retinal imaging ow.ly/Oh9O50V0j7u
2
232
@EssiLux has acquired Cellview Imaging and its ultra-widefield retinal technology. See what’s next for the company amidst a flurry of acquisitions in eye care: piemagazine.org/essilorluxot… #Ophthalmology #EssilorLuxotica #CellviewImaging #MediaMICE

2
22
EssilorLuxottica übernimmt Cellview: Die Ultraweitwinkel-Technologie des kanadischen Medizintechnik-Start-ups ermöglicht schnelle und einfache Bilder in hoher Qualität und bietet einen umfassenden Blick auf die Netzhaut. dlvr.it/THwBgb

1
43
11 Feb 2025
EssilorLuxottica acquisisce la startup med-tech canadese Cellview, specializzata in soluzioni che "facilitano la diagnosi delle patologie della retina, grazie a una fotocamera retinica ultra-widefield in grado di generare immagini a campo significativamente più ampio rispetto alla maggior parte delle tecnologie esistenti" si legge in un comunicato
19
1,448
Did you know that BD CellView™ Image Technology utilizes technology from the wireless communication industry to obtain multicolor fluorescent images in real time. See how it can be utilized in your research bit.ly/3UsINBt #FactsaboutFACS #BDBiosciences #flowcytometry
1
3
442
18 Sep 2024
ポストレイアウトシミュレーションするときにDesign VariablesをCopy from Cellview すると... 固まる! あたりまえ体操(2敗)
3
3
254
12 Jun 2024
The installation of the country's first FACSDiscover S8 with CellView at IBP CAS marks the beginning of a new era of cell sorting and imaging. Many thanks @Akademie_ved_CR and @EvaIbp for their great support and also @BDBiosciences for providing excellent service. We're excited🤩
4
23
620
Come by booth #74 and meet the scientists behind BD innovations. Today at 14:45 – 15:30 we’ll be discussing BD CellView™ Image Technology, panel design and dye development. Learn more bit.ly/4b5Wqgi #CYTO2024 #BDBiosciences #BDCellView #BDFACSDiscoverS8 #RTISFC
5
548
At #CYTO2024? This year we are excited to introduce our 3- and 4-laser BD FACSDiscover™ S8 Cell Sorters with BD CellView™ Image Technology and BD SpectralFX™ Technology. Stop by booth #74. bit.ly/4aaDZWe #BDBiosciences #FACSDiscoverS8 #rtisfc #singlecellmultiomics
4
404
Looking to add morphological insights to cell sorting? Check out the chapter on image-enabled cell sorting using the BD CellView™ Image Technology in Flow Cytometry Protocols. Read the chapter bit.ly/3wjbSq1 #BDBiosciences #BDCellView #flowcytometry #springer
3
8
591
5 Apr 2024
BD announced new BD FACSDiscover™ S8 Cell Sorters feature BD CellView™ Image Technology, profiled on the cover of the journal Science in 2022, and BD SpectralFX™ Technology. news.bd.com/2024-04-05-BD-In…
1
6
734
Forensic Analytics is delighted to announce a new partnership with @solv_tech. This collaboration will see SOLV work hand in hand with Forensic Analytics product - CellView - to enable validation of postcode targeted messaging. Full details can be found below: hubs.la/Q02nyrrg0 #TechForGood | #Partnership | #CommunicationsData
1
4
157